Statistics
Publications
29
Citations
3K
H-Index
22
Active since
1993
Daniel A. Erlanson is an author at Sunesis (United States) specializing in drug discovery, medicinal chemistry, and pharmacy.
Publications per year
1993–2025
29
29
Allosteric inhibition of protein tyrosine phosphatase 1B
Christian Wiesmann, Kenneth J. Barr, Jenny Kung et al. · Nature Structural & Molecular Biology · 2004 · 530 citations
Site-directed ligand discovery
Daniel A. Erlanson, Andrew C. Braisted, D.R. Raphael et al. · Proceedings of the National Academy of Sciences · 2000 · 466 citations
Unexpected Effect of Proton Pump Inhibitors
Yohannes T. Ghebremariam, Paea LePendu, Jerry C. Lee et al. · Circulation · 2013 · 254 citations
Medicine, Cardiology, Pharmacology +16
György M. Keserű, Daniel A. Erlanson, György G. Ferenczy et al. · Journal of Medicinal Chemistry · 2016 · 233 citations
In situ assembly of enzyme inhibitors using extended tethering
Daniel A. Erlanson, Joni W. Lam, Christian Wiesmann et al. · Nature Biotechnology · 2003 · 200 citations
1–5 of 29